Hepakind 300mg Tablet contains Ursodeoxycholic Acid, a hydrophilic bile acid used primarily in the treatment of various hepatobiliary disorders. It is indicated for the dissolution of cholesterol gallstones in patients with a functioning gallbladder and for the management of primary biliary cholangitis (PBC), a chronic autoimmune liver disease characterized by progressive destruction of intrahepatic bile ducts. Ursodeoxycholic Acid acts by reducing the cholesterol content of bile, thereby decreasing cholesterol saturation and promoting the gradual dissolution of gallstones. Additionally, it exhibits cytoprotective properties by stabilizing hepatocyte membranes, reducing apoptosis, and improving bile flow, which helps alleviate cholestasis and liver inflammation. Hepakind is typically administered orally, with dosage tailored according to the specific condition and patient response. Common side effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort, though it is generally well tolerated. Caution is advised in patients with complete biliary obstruction or severe liver dysfunction. Regular monitoring of liver function tests is recommended during therapy to assess treatment efficacy and detect potential adverse effects. Hepakind 300mg Tablet should be used under medical supervision to ensure optimal therapeutic outcomes.